Boehringer Ingelheim Pharmaceuticals, Inc

Director, Early Safety Immunology

Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. in Immunology or equivalent with around ten years of pharmaceutical industry experience.
  • Extensive background in laboratory immune safety assessments and mechanistic derisking.
  • Strong management and supervisory experience with a focus on staff development.
  • Proven ability to lead teams in dynamic and changing environments.
  • Established reputation or publication record in immunology, toxicology, or cell/molecular biology.

Responsibilities

  • Manages a team conducting investigations into immune safety toxicology during early drug development.
  • Oversight of Early Safety Immunology, establishing strategies and evaluating scientific outputs.
  • Maintains operational control and resource distribution within Early Safety Immunology functions.
  • Guides interpretation of various data types to understand immune safety liabilities and develop biomarkers.
  • Stays updated on scientific and regulatory trends, seeking new work opportunities.
  • Ensures early safety strategies are fit for innovative immune modulating concepts.
  • Provides comprehensive recommendations to senior management.

Benefits

  • Onsite with flexible remote working options; minimum onsite requirement of 2-3 days per week.
  • Continued professional development opportunities for staff.
  • Engagement with a collaborative network of scientists and stakeholders.
  • Work in a cutting-edge field with novel modeling and technology applications.
Full Job Description
The primary objective of the Director Early Safety Immunology role is to lead Early Safety immunology, tasked with proactively developing and utilizing novel models/technologies to ensure tailored, modality driven safety evaluations of immune therapeutics during discovery, preclinical and clinical development. The incumbent ensures appropriate assignment of scientists to projects, suitable technology and collaborative investments, and delivery of the highest quality mechanistic data/interpretation to support portfolio decisions. Guiding the professional and personal development of staff is a critical responsibility for this role. The position works closely with the other functional heads within Nonclinical/Early Safety Sciences, CPS TAs, CI and Discovery Research to drive early identification, understanding and mitigation of immune-related safety risks. Duties & Responsibilities • Manages a team conducting investigative toxicology studies (focus immune safety) supporting early discovery, preclinical and clinical development; implementing nontraditional approaches to advance/rescue compounds and to predict and/or understand immune mediated toxicities. • Provides scientific oversight of Early Safety Immunology, including developing strategy, establishing context (internal & external), evaluating output/reports, and ensuring accurate delivery of results to senior management and project teams. • Maintains operational control of functions within Early Safety Immunology, including balancing assignments, monitoring workload, maintaining standards/compliance and distributing resources. • Guides interpretation of computational, molecular, in vitro, cellular and immunotoxicology data and supports the utilization of these data for understanding mechanisms of immune safety liabilities, in developing novel biomarkers, and/or in developing predictive & analytical tools. • Maintains up-to-date expertise in pertinent scientific and regulatory areas and identifies opportunities/trends to develop and guide new avenues of work. • Ensures fit for purpose and modality driven early safety strategies for innovative immune modulating concepts. • Provides bottom lines and recommendations to senior management (Global Head, VP & above). • Complies with all ICH, FDA, EPA, OSHA and company regulations and policies. • Excellent collaboration with a wide range of scientists within the IU and maintaining a network of resources both internally and externally to develop projects/strategies appropriately to achieve critical goals. Requirements • Ph.D. in Immunology or equivalent with roughly ten (10) years' experience in the pharmaceutical industry required. • Extensive experience in laboratory-based immune safety assessments, mechanistic derisking studies, and the ability to lead the scientists engaged in these studies. • Well-developed management and supervisory skills, with proven experience in leading and developing staff, including senior scientists. • Ability to operate effectively in dynamic, evolving environments and guide teams through ambiguity. • Established reputation and/or publication record, preferably in the fields of immunology, toxicology, or cell/molecular biology. • Excellent written and verbal communications skills. • Onsite/Flex*: This position is site based with flexibility for remote working. Working onsite a minimum of 2-3 days per week is required. Remote working norms will be clarified during the interview process. Eligibility Requirements : • Must be legally authorized to work in the United States without restriction. • Must be willing to take a drug test and post-offer physical (if required). • Must be 18 years of age or older. Compensation Data The base salary range for this position is $200,000.00 to $316,000.00 USD. The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law. For an overview of our benefits please click here.

About Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Pharmaceuticals, Inc. is a research-driven pharmaceutical company that discovers, develops, and manufactures prescription medicines. The company's mission is to improve the health and quality of life of patients by developing innovative therapies. Boehringer Ingelheim Pharmaceuticals, Inc. is a subsidiary of Boehringer Ingelheim Corporation, which is headquartered in Ingelheim, Germany. The company's research and development efforts focus on respiratory diseases, immunology, oncology, and diseases of the central nervous system. Boehringer Ingelheim Pharmaceuticals, Inc. was founded in 1885 and is based in Ridgefield, Connecticut.
Learn more about Boehringer Ingelheim Pharmaceuticals, Inc
Size
5,000 employees
Industry

Similar Jobs

More Jobs at Boehringer Ingelheim Pharmaceuticals, Inc

More Pharmaceuticals & Biotech Jobs

Find similar Director, Early Safety Immunology jobs: